— Know what they know.
Not Investment Advice

EMBC

Embecta Corp.
1W: +1.6% 1M: -11.2% 3M: -24.8% YTD: -21.7% 1Y: -27.4% 3Y: -66.2%
$9.00
-0.01 (-0.11%)
After Hours: $9.04 (+0.04, +0.50%)
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $533.0M · Alpha Radar Strong Sell · Power 32
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$533.0M
52W Range8.72-15.55
Volume706,301
Avg Volume781,754
Beta1.06
Dividend$0.60
Analyst Ratings
1 Buy 1 Hold 2 Sell
Consensus Sell
Company Info
CEODevdatt Kurdikar
Employees2,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-03-22
300 Kimball Drive
Parsippany, NJ 07054
US
201 847 6880
About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Recent Insider Trades

NameTypeSharesPriceDate
Pomeroy Claire A-Award 22,841 2026-02-11
Reidy Christopher R A-Award 22,841 2026-02-11
HOMBACH ROBERT J. A-Award 22,841 2026-02-11
Morris Milton Mayo A-Award 22,841 2026-02-11
Prange Karen A-Award 22,841 2026-02-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms